JENA, Germany--(BUSINESS WIRE)--SIRS-Lab, a leader in molecular diagnostics, sees its eight years of operational business as the foundation for expected strong growth. Initially funded in March 2001 by bm-t beteiligungsmanagement thüringen, the company has grown to become an established player in the sepsis field, with a unique product suite in sepsis diagnostics, and products on the market. Eight years on, the company’s innovative spirit, carried by a dedicated team, is still the main driver and guarantor for success.
